Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Phenotypic changes of leukemic cells in a patient with prolympho-plasmacytic leukaemia after treatment with fludarabine.

European journal of histochemistry : EJH - 1 Jan 1997

Loria M P, Dell'Osso A, Grande M, Dambra P, D'Oronzio L, Crollo R, Lasaracina E, Lucivero G

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Antigens, CD
Share to Antineoplastic Agents
Share to Immunophenotyping

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Immunosuppressive Agents

Share to Lymphocytes

Share to Phenotype

Share to Vidarabine

Source

Identifiers

PMID: 9859769

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Phenotypic changes of leukemic cells in a patient with prolympho-plasmacytic leukaemia after treatment with fludarabine.PMID 9859769Read ↗

Prolymphocytic leukemia with suppressor T-cell phenotype: report of two cases.Semantic proximity Read ↗

[Leukemic immunophenotyping with flow cytometry].Semantic proximity Read ↗

Case-control study of multidrug resistance phenotype and response to induction treatment including or not fludarabine in newly diagnosed acute myeloid leukaemia patients.Semantic proximity Read ↗

Abnormal phenotype of bone marrow plasma cells in patients with chronic myeloid leukemia undergoing therapy with Imatinib.Semantic proximity Read ↗

Unusual immunological phenotypes among 104 acute leukemias classified according to the FAB criteria.Semantic proximity Read ↗

[Flow cytometry: application for the diagnosis and the follow-up of hematological malignancies].Semantic proximity Read ↗

Flow cytometry in hematological nonmalignant disorders.Semantic proximity Read ↗

Phenotypic clues that predict underlying cytogenetic/genetic abnormalities in myeloid malignancies: A contemporary review.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.